Compugen CGEN
NASDAQ CGEN
$2.09 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Compugen (CGEN) Operating Interest Expenses (2011 - 2012)

Updated

Compugen's Operating Interest Expenses came in at -$1.53 million for Q4 2012, compared with -$1.32 million a year earlier.

Analysis

Compugen (CGEN) Operating Interest Expenses (2011 - 2012) Analysis & Trends

For FY2012, Compugen's Operating Interest Expenses was -$86,000.

  • Going back by year, Operating Interest Expenses was -$306,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Compugen 197.62 Mn -218.36 Mn 1.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -1.53 Mn
Dec 31, 2011 -1.32 Mn
API Access

Compugen Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=CGEN&period=max&api_key=YOUR_API_KEY